Tag
In its first global guideline on childhood obesity, the WHO says medicines such as GLP-1 drugs should be considered only for adolescents, and only after a supervised lifestyle program has not worked. No drugs or surgery for children nine and under.
The deal, worth up to $2.6 billion, gives Novo an early-stage oral GLP-1/GIP drug designed to be taken once a week — a bid to leapfrog today’s daily pills as its rivalry with Lilly intensifies.
TrumpRx.gov lists discounted cash prices for brand-name drugs, including GLP-1s such as Zepbound, Wegovy and Ozempic. Here is how it works, what the prices are, and when it is — and isn’t — the cheapest option.
Lilly’s triple-hormone drug produced some of the largest weight loss ever seen in obesity trials. It isn’t approved yet — and a fast-growing online market selling it as a “research peptide” carries real dangers.
Both are once-daily GLP-1 tablets for weight loss, and both start at $149 a month. But they are very different drugs — and the differences in how you take them, how much weight people lost, and what higher doses cost are worth knowing.